Whether GLIPR1 promoter methylation is dynamic during disease progression or shows higher or lower levels of methylation in metastatic melanoma cells compared to normal melanocytes, benign nevi and primary melanoma remains unknown and requires further investigation. This evidence concerns the gene GLIPR1 and melanoma.